These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34901968)

  • 21. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
    Lee HJ; Ahn BC; Lee SW; Lee J
    Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 FDG PET/CT imaging of solitary liver Langerhans cell histiocytosis: preliminary findings.
    Hu X; Dong A; Lv S; Wang Q; Zhan X; Song X; Wang J
    Ann Nucl Med; 2012 Jun; 26(5):436-9. PubMed ID: 22396242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. F18-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of vertebral vascular tumors.
    Song L; Han S; Jiang L; Zhang W
    Clin Imaging; 2020 Sep; 65():24-32. PubMed ID: 32353715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations.
    Agarwal KK; Seth R; Behra A; Jana M; Kumar R
    Jpn J Radiol; 2016 Apr; 34(4):267-76. PubMed ID: 26759026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging
    Rameh V; Voss S; Bedoya MA; Beaulieu D; Zhang D; Degar BA; Tsai A
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30057. PubMed ID: 36266951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Rare Widespread Cutaneous Langerhans Cell Histiocytosis Manifested on 18 F-FDG PET/CT.
    Wang L; Zhang Y; Wu H
    Clin Nucl Med; 2022 Oct; 47(10):e647-e648. PubMed ID: 35543631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG PET/CT in Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease.
    Ngo VT; Wassef HR
    Clin Nucl Med; 2022 Aug; 47(8):732-735. PubMed ID: 35293357
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Wang Z; Ma D; Yang J
    Hell J Nucl Med; 2016; 19(3):241-244. PubMed ID: 27824963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerhans Cell Histiocytosis of Bilateral Parotid and Submandibular Glands: Findings on 18F-FDG PET/CT.
    Prakash S; Shamim SA; Bakhshi S; Pushpam D; Sharma A
    Clin Nucl Med; 2023 Apr; 48(4):e200-e201. PubMed ID: 36728145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of nociceptive-related metabolic activity in the spinal cord of low back pain patients using
    Zhou X; Cipriano P; Kim B; Dhatt H; Rosenberg J; Mittra E; Do B; Graves E; Biswal S
    Scand J Pain; 2017 Apr; 15():53-57. PubMed ID: 28850345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of
    Sevaslidou I; Papavasileiou P; Gavra M; Baka M; Polychronopoulou S; Gogou L
    Hell J Nucl Med; 2023; 26(3):215-218. PubMed ID: 38149775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
    An R; Ma X; Wang Y
    Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma.
    Szturz P; Řehák Z; Koukalová R; Adam Z; Krejčí M; Pour L; Zahradová L; Vaníček J; Nebeský T; Hájek R; Mayer J
    Nucl Med Biol; 2012 Apr; 39(3):429-36. PubMed ID: 22172385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.
    Loudini N; Glaudemans AWJM; Jutte PC; Yakar D; Kwee TC
    Skeletal Radiol; 2020 Sep; 49(9):1387-1395. PubMed ID: 32253470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment on: Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
    Mamdouhi T; Desai P; Goodman HJ; Amodio JB; Edelman MC; Rich BS; Glick RD; Lipton JM; Levy CF
    Pediatr Blood Cancer; 2022 May; 69(5):e29504. PubMed ID: 34913590
    [No Abstract]   [Full Text] [Related]  

  • 38. Physiological uptake of 18F-FDG in the vertebral bone marrow in healthy adults on PET/CT imaging.
    Shen G; Liang M; Su M; Kuang A
    Acta Radiol; 2018 Dec; 59(12):1487-1493. PubMed ID: 29486597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [
    Guo L; Shen G
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2520-2521. PubMed ID: 38459977
    [No Abstract]   [Full Text] [Related]  

  • 40. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults.
    Huang WD; Yang XH; Wu ZP; Huang Q; Xiao JR; Yang MS; Zhou ZH; Yan WJ; Song DW; Liu TL; Jia NY
    Spine J; 2013 Sep; 13(9):1108-17. PubMed ID: 23602327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.